Drug Updates

No need to go searching all over for the latest information on new drugs, indications, medication errors and more.  You can find the latest journal articles and CE activities from our 50+ nursing journals, plus get access to new drug information and patient teaching aids from Nursing2013 Drug Handbook, all right here!

 Drug News

 Resources from NDHNow
 Browse Journal Articles and CE by Topic  Featured LWW Product
 Medication Errors  
 

Drug News

(from Drug News Weekly) 

The FDA has made the following approvals:

  • Breo Ellipta (fluticasone furoate/vilanterol) inhalation powder for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is also approved to reduce exacerbations of COPD in patients with a history of exacerbations.
  • Liptruzet (ezetimibe/atorvastatin) as an adjunct to diet for the treatment of high low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia.
  • Actemra (tocilizumab) injection for the treatment of polyarticular juvenile idiopathic arthritis in patients 2 years and older.

The FDA has notified health care providers that the use of the incorrect generic name for Kadcyla (ado-trastuzumab emtansine) in some medication-related electronic systems poses a risk of confusion with Herceptin (trastuzumab), resulting in potential medication errors and harm to patients due to different dosing and treatment schedules.

The FDA is adding a new Black Box Warning for Pradaxa (dabigatran etexilate mesylate) concerning an increased risk of stroke when discontinuing use in patients without adequate continuous anticoagulation.

The FDA is advising health care providers that valproate sodium and related products valproic acid and divalproex sodium are contraindicated in pregnant women for the prevention of migraine headaches.

Medication Errors

 

In the March 2013 issue of Nurse Advise-ERR, ISMP gives the following recommendations to avoid errors when switching from insulin pens to insulin vials in the hospital:

  • Alert staff to the upcoming change and re-educate regarding proper medication preparation and administration.
  • When possible, have pharmacy prepare and dispense insulin doses. For rapid-acting insulin dosing, have pharmacy dispense a vial (preferably 3 mL) for specific patient.
  • Stock the smallest vials to help avoid any catastrophic dosing errors.
  • Stock appropriate syringes.
  • Label all vials and syringes.
  • Don’t leave insulin vials on counters or on top of medication carts; return them to the appropriate storage location.
  • Anticipate and address problems that may arise with this transition.

Browse Journal Articles and CE by Topic
  Anti-infectives   Medication Errors
  Cardiovascular Drugs   Neurologic Drugs
  Complementary and Alternative Medicine   New Drugs
  Endocrine Drugs   Pain Control
  Gastrointestinal Drugs   Psychiatric Drugs
  Genitourinary Drugs   Respiratory Drugs
  Immunologic Drugs

Resources from NDHNow
Check out the newest updates, timely tips and more resources and features from the publisher of Nursing2013 Drug Handbook. 
 New drugs and indications - Keep current with need-to-know information on recently approved drugs and new indications.    Drug Warnings - Check this feature for cautions from drug manufacturers and the Food and Drug Administration.
 Patient TeachingPrint and hand out patient teaching aids on new drugs.   Herbal Spotlight - Discover essential information on commonly used herbs.
 News Capsules - Keep current with these news summaries on recent drug developments from Nursing2013 Drug Handbook.  

Featured LWW Product

 

The Nursing2013 Drug Handbook -- the 33rd edition of the best-selling, original drug handbook for nurses -- provides complete monographs for more than 900 generic and 3,000 trade drugs.